PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:30 AM ET

Sponsor Check › Person

DD
No photo found yet (own website and image search run after this page is viewed)

Dan Dearborn

Named as an officer, director or promoter on SEC Form D filings · FL · Jul 3, 2019 → Nov 10, 2025

2deals (issuers)
$30.9Mreported sold
201investors
5Form D filings
2019–2025years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:16 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Dan Dearborn is listed as an executive officer on 5 SEC Form D filings by 2 issuers between Jul 2019 and Nov 2025: TuHURA Biosciences, Inc./NV (Tampa, FL — biotechnology — 2025; $21.8M reported sold to 161 investors) and TuHURA Biosciences, Inc. (Tampa, FL — biotechnology — 2019–2023; $9.1M reported sold to 40 investors).

What this means 2 separate companies raised money with this person listed as executive officer, over about 6 years. Across those companies the filings report $30.9M sold in total.

Listed alongside George Ng (4 shared filings), James Bianco (4 shared filings), Alan List (3 shared filings), James Manuso (3 shared filings), Kiran C Patel (3 shared filings) and 9 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Dan. Each name links to their own page.

All 2 issuers belong to the sponsor group Tuhura Biosciences (2 issuers, $3.17M reported sold, 2013–2025).

What this means A sponsor group is one team that sets up a new company for each deal. Tuhura Biosciences has 2 companies on file and $3.17M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 5 public filings for Dan Dearborn and found 4 differences: Form D filed 16 days after the first sale; Form D filed 17 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Dan Dearborn has not run yet — it is joining a line of 17,779 names; searches run around the clock at the hosts' allowed rate. Searched so far: 28 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:16 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Dan Dearborn..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:16 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

4 differences found between the filings for Dan Dearborn (compared 5 filings on Oct 24, 2026)

Note · Dec 11, 2023 – Dec 27, 2023

Form D filed 16 days after the first sale — TuHURA Biosciences, Inc.

The filing says the first sale was Dec 11, 2023. The Form D was filed Dec 27, 2023 — 16 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 1 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Jun 24, 2022 – Jul 11, 2022

Form D filed 17 days after the first sale — TuHURA Biosciences, Inc.

The filing says the first sale was Jun 24, 2022. The Form D was filed Jul 11, 2022 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Jun 20, 2019 – Jun 13, 2025

4 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — TuHURA Biosciences, Inc./NV (latest filing Jun 13, 2025) · No amendment in the last 12 months on an offering that may still be open — TuHURA Biosciences, Inc. (latest filing Dec 27, 2023) · No amendment in the last 12 months on an offering that may still be open — TuHURA Biosciences, Inc. (latest filing Jul 11, 2022) · No amendment in the last 12 months on an offering that may still be open — TuHURA Biosciences, Inc. (latest filing Jul 3, 2019)

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Sources
Note · Jul 3, 2019

Formed in 2023 per the latest filing, but activity is dated 2019 — TuHURA Biosciences, Inc.

The issuer's latest filing says it was formed in 2023. The Jul 3, 2019 filing says the first sale was Jun 20, 2019 — before that year.

What this means A company cannot sell before it exists, so one of the two dates is likely a typo on the form. Ask the sponsor for the formation document.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

3 of 5 offerings report sales commissions totalling $2,281,273; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Nov 10, 2025 D
TuHURA Biosciences, Inc./NV
File 021-563591
$0$0$0None listed on this filingEDGAR ↗
Jun 13, 2025 D
TuHURA Biosciences, Inc./NV
File 021-548881
$948,073$0$0Paulson Investment Company, LLC BrokerCheck CRD 5670 ↗
Brookline Capital Markets, a division of Arcadia Securities, LLC BrokerCheck CRD 44656 ↗
EDGAR ↗
Dec 27, 2023 D
TuHURA Biosciences, Inc.
File 021-500849
$133,200 (est.)$0$0Paulson Investment Company LLC BrokerCheck CRD 5670 ↗EDGAR ↗
Jul 11, 2022 D
TuHURA Biosciences, Inc.
File 021-451829
$0$0$0None listed on this filingEDGAR ↗
Jul 3, 2019 D
TuHURA Biosciences, Inc.
File 021-343530
$1,200,000 (est.)$0$0Skyway Capital Markets, LLC BrokerCheck CRD 124630 ↗
Paulson Investment Company, LLC BrokerCheck CRD 5670 ↗
EDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 2

Every issuer that named Dan Dearborn on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology · group: Tuhura Biosciences

TuHURA Biosciences, Inc./NV

Tampa, FL · Jun 13, 2025 → Nov 10, 2025 · 2 filings
  • Nov 10, 2025 · D · $1,500,000 sold of $3,000,000 · 1 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Jun 13, 2025 · D · $2,228,043 sold of $12,612,120 · 36 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $21.8M from 161 investors (100% of the $3M target) as of the latest filing. Dan is listed as executive officer on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology · group: Tuhura Biosciences

TuHURA Biosciences, Inc.

Tampa, FL · Jul 3, 2019 → Dec 27, 2023 · 3 filings
  • Dec 27, 2023 · D · $1,665,000 sold of $15,000,000 · 8 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Jul 11, 2022 · D · $9,101,001 sold of $20,000,000 · 2 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Jul 3, 2019 · D · $495,000 sold of $15,000,000 · 5 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $9.1M from 40 investors (61% of the $15M target) as of the latest filing. Dan is listed as executive officer on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(c) (163 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Dan 14

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

GN
No photo found yet (own website and image search run after this page is viewed)
Person

George Ng

Director · 4 shared filings (2 issuers)

Listed on the same filings as Dan Dearborn. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

James Bianco

Executive Officer, Director · 4 shared filings (2 issuers)

Listed on the same filings as Dan Dearborn. Their page shows their other deals.

AL
No photo found yet (own website and image search run after this page is viewed)
Person

Alan List

Director · 3 shared filings (2 issuers)

Listed on the same filings as Dan Dearborn. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

James Manuso

Director · 3 shared filings (2 issuers)

Listed on the same filings as Dan Dearborn. Their page shows their other deals.

PL
No photo found yet (own website and image search run after this page is viewed)
Person

Patricia Dianne Lawman

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Dan Dearborn. Their page shows their other deals.

ML
No photo found yet (own website and image search run after this page is viewed)
Person

Michael John Lawman

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Dan Dearborn. Their page shows their other deals.

KP
No photo found yet (own website and image search run after this page is viewed)
Person

Kiran C Patel

Director · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Dan Dearborn. Their page shows their other deals.

CT
No photo found yet (own website and image search run after this page is viewed)
Person

Craig Tendler

Director · 2 shared filings (1 issuer)

Listed on the same filings as Dan Dearborn. Their page shows their other deals.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Hoffman

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Dan Dearborn. Their page shows their other deals.

PS
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Staats

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Dan Dearborn. Their page shows their other deals.

JE
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph P. Errico

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Dan Dearborn. Their page shows their other deals.

DB
No photo found yet (own website and image search run after this page is viewed)
Person

David Bergmann

Director · 1 shared filing (1 issuer)

Listed on the same filings as Dan Dearborn. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Shamblott

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Dan Dearborn. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

James McNulty

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Dan Dearborn. Their page shows their other deals.

The team behind the deals

Sponsor group

Tuhura Biosciences

2 issuers · 19 filings · $3.17M reported sold · 2013–2025

One team, 2 deal companies. Dan Dearborn is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Dan Dearborn.

Registrations and other filings

Adviser registration (Form ADV)

None of the 2 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Dan Dearborn by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 2 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Dan Dearborn is listed on: none on file. No website or social profile named in TuHURA Biosciences, Inc./NV's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #55,290 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Tampa, FL). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Dan Dearborn appears on a new Form D, or when a court case or SEC action is matched to them. See plans →